EWA and FXI look good to me, stable and less risk, relatively speaking.  not sure about cc, since there are other competitors out there, such as bb.  little bit worried about TRMM, though.

for that bio company, it's ok only if they have a timeline of when the new product can be delivered.

i need to 'find' some real cash as well.